Skip to main content
Robert Sidonio Jr., MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

RobertFrancisSidonioJr.MD

Pediatric Hematology & Oncology Atlanta, GA

Pediatric Coagulation Disorder Hematology

Associate Professor Of Pediatrics, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University.

Dr. Sidonio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sidonio's full profile

Already have an account?

Education & Training

  • University of Pittsburgh
    University of PittsburghMS, Clinical Research , 2008 - 2010
  • UPMC Medical Education
    UPMC Medical EducationFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Pediatrics, 2004 - 2007
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2004
  • Troy State University
    Troy State UniversityBS, Biology, Magna Cum Laude, 1994 - 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - 2023
  • GA State Medical License
    GA State Medical License 2014 - 2023
  • TN State Medical License
    TN State Medical License 2010 - 2014
  • PA State Medical License
    PA State Medical License 2007 - 2010
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • HOG Georgia Clinical Scientist Award Hemophilia of Georgia
  • HTRS Mentored Research Award Hemostasis and Thrombosis Research Society, 2014-2016
  • NHF Capacity Building Grant National Hemophilia Foundation, 2013-2016
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Successful combination therapy of a proximal haemophilic pseudotumor with surgery, radiation and embolization in a child with mild haemophilia A.  
    Ahuja, SJ, Sidonio RF, Raj AB, Bertolone SJ, Silverman, A. Haemophilia. 2007 Mar;13(2):209-212
  • Screening for VWD in Children: A Case Control Study.  
    Bujnicki HC, Sidonio RF, Kempton C, Kouides PA, Kulkarni R, Nugent DJ, Yee DL, Moore CG, Ragni MV, J Thromb Haemost. 2011 May;9(5):1086-90
  • Proteinase expression during differentiation of human osteoclasts in vitro.  
    Blair HC, Sidonio RF, Friedberg RC, Khan NN, Dong SS, J Cell Biochem. 2000 Jun 12;78(4):627-37

Abstracts/Posters

  • The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study
    Robert F. Sidonio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Case control Feasibility Study of Bleeding Genotype and Phenotype in Hemophilia A Carriers.
    Sidonio RF, DeBaun MR, Region IV Hemophilia Meeting, Ft. Lauderdale, FL
  • In Vitro and In Vivo Characterization of Single and Double Mutant HSV-1 in the Syngeneic Murine 4C8 Glioma Model.
    Sidonio RF, Parker J, Markert J, Whitley R, UAB Medical School Research Day
  • Join now to see all

Lectures

  • Real World Use of Extended Half-Life Products and the Impact on Bleeding Events and Joint Health in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Bleeding in Hemophilia A Carriers. 
    Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting, Memphis, TN

Other

  • Von Willebrand Disease Screening in Adolescents with Menorrhagia: A Decision Analysis and Review. 
    Sidonio RF, Ragni MV, Touch Briefings 2011 U.S Oncology & Hematology 7(2):146-149

Press Mentions

  • Catalyst Biosciences Releases Update on Trial of Factor IX Treatment of Severe Hemophilia B
    Catalyst Biosciences Releases Update on Trial of Factor IX Treatment of Severe Hemophilia BJune 19th, 2018
  • Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A Patients
    Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A PatientsAugust 29th, 2019
  • Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study Finds
    Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study FindsSeptember 9th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations